ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.
Inv Msci Emerg

Inv Msci Emerg (MXFS)

52.255
0.00
( 0.00% )
Actualizado: 03:35:35

Discusiones en tiempo real e ideas comerciales: opere con confianza con nuestra poderosa plataforma.

Estadísticas y detalles clave

Último Precio
52.255
Postura de Compra
52.66
Postura de Venta
52.74
Volume Operado de la Acción
5
0.00 Rango del Día 0.00
0.00 Rango de 52 semanas 0.00
Precio Anterior
52.255
Precio de Apertura
-
Última hora de negociación
02:00:00
Volumen promedio (3 m)
-
Volumen financiero
-
Precio Promedio Ponderado
-

MXFS Últimas noticias

IVZ MSCI Emerging Mkts UCITS $ Net Asset Value(s)

IVZ MSCI Emerging Mkts UCITS $ 24 January 2025   FUND: Invesco MSCI Emerging Markets UCITS ETF DEALING DATE: 23-Jan-25 NAV PER SHARE: USD:52.1856 NUMBER OF SHARES IN ISSUE: 7,488,545.00 CODE:...

IVZ MSCI Emerging Mkts UCITS $ Net Asset Value(s)

IVZ MSCI Emerging Mkts UCITS $ 23 January 2025   FUND: Invesco MSCI Emerging Markets UCITS ETF DEALING DATE: 22-Jan-25 NAV PER SHARE: USD:52.2335 NUMBER OF SHARES IN ISSUE: 7,488,545.00 CODE:...

IVZ MSCI Emerging Mkts UCITS $ Net Asset Value(s)

IVZ MSCI Emerging Mkts UCITS $ 22 January 2025   FUND: Invesco MSCI Emerging Markets UCITS ETF DEALING DATE: 21-Jan-25 NAV PER SHARE: USD:52.1735 NUMBER OF SHARES IN ISSUE: 7,488,545.00 CODE:...

IVZ MSCI Emerging Mkts UCITS $ Net Asset Value(s)

IVZ MSCI Emerging Mkts UCITS $ 22 January 2025   FUND: Invesco MSCI Emerging Markets UCITS ETF DEALING DATE: 21-Jan-25 NAV PER SHARE: USD:52.1735 NUMBER OF SHARES IN ISSUE: 7,488,545.00 CODE:...

IVZ MSCI Emerging Mkts UCITS $ Net Asset Value(s)

IVZ MSCI Emerging Mkts UCITS $ 21 January 2025   FUND: Invesco MSCI Emerging Markets UCITS ETF DEALING DATE: 20-Jan-25 NAV PER SHARE: USD:52.1443 NUMBER OF SHARES IN ISSUE: 7,488,545.00 CODE:...

IVZ MSCI Emerging Mkts UCITS $ Net Asset Value(s)

IVZ MSCI Emerging Mkts UCITS $ 20 January 2025   FUND: Invesco MSCI Emerging Markets UCITS ETF DEALING DATE: 17-Jan-25 NAV PER SHARE: USD:51.6442 NUMBER OF SHARES IN ISSUE: 7,488,545.00 CODE:...

IVZ MSCI Emerging Mkts UCITS $ Net Asset Value(s)

IVZ MSCI Emerging Mkts UCITS $ 17 January 2025   FUND: Invesco MSCI Emerging Markets UCITS ETF DEALING DATE: 16-Jan-25 NAV PER SHARE: USD:51.4732 NUMBER OF SHARES IN ISSUE: 7,543,545.00 CODE:...

IVZ MSCI Emerging Mkts UCITS $ Net Asset Value(s)

IVZ MSCI Emerging Mkts UCITS $ 16 January 2025   FUND: Invesco MSCI Emerging Markets UCITS ETF DEALING DATE: 15-Jan-25 NAV PER SHARE: USD:50.9476 NUMBER OF SHARES IN ISSUE: 7,543,545.00 CODE:...

IVZ MSCI Emerging Mkts UCITS $ Net Asset Value(s)

IVZ MSCI Emerging Mkts UCITS $ 15 January 2025   FUND: Invesco MSCI Emerging Markets UCITS ETF DEALING DATE: 14-Jan-25 NAV PER SHARE: USD:50.8141 NUMBER OF SHARES IN ISSUE: 7,543,545.00 CODE:...

IVZ MSCI Emerging Mkts UCITS $ Net Asset Value(s)

IVZ MSCI Emerging Mkts UCITS $ 14 January 2025   FUND: Invesco MSCI Emerging Markets UCITS ETF DEALING DATE: 13-Jan-25 NAV PER SHARE: USD:50.141 NUMBER OF SHARES IN ISSUE: 7,543,545.00 CODE:...

Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
10000000SP
40000000SP
120000000SP
260000000SP
520000000SP
1560000000SP
2600000000SP

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
STBXStarBox Group Holdings Ltd
US$ 0.9158
(79.53%)
4.03M
EVAXEvaxion Biotech AS
US$ 6.22
(70.88%)
1.42M
DWTXDogwood Therapeutics Inc
US$ 18.68
(39.93%)
771.64k
FSEAFirst Seacoast Bancorp Inc
US$ 14.00
(38.62%)
16
NVNINVNI Group Ltd
US$ 1.87
(25.50%)
844.94k
NOEMCO2 Energy Transition Corporation
US$ 5.00
(-49.49%)
204
MDXGMiMedx Group Inc
US$ 5.11
(-43.41%)
50
HYZNHyzon Motors Inc
US$ 0.4375
(-43.33%)
16.9k
IROQIF Bancorp Inc
US$ 14.01
(-41.89%)
3
LRFCLogan Ridge Finance Corporation
US$ 14.01
(-41.65%)
6
BTAIBioXcel Therapeutics Inc
US$ 0.4743
(24.88%)
10.03M
STBXStarBox Group Holdings Ltd
US$ 0.9158
(79.53%)
4.03M
ACONAclarion Inc
US$ 0.05
(15.74%)
3.53M
SHViShares Short Treasury Bond ETF
US$ 110.415
(0.03%)
2.5M
LITMSnow Lake Resources Ltd
US$ 0.9509
(-31.59%)
1.98M
Wingsjr Wingsjr 5 minutos hace
Thx for this. I’ve shared it on Stocktwits and my discord.
FNMA
benhor benhor 5 minutos hace
$ACON exploding on Pre-Market 

0.0578 +0.0146 33.80%
ACON
benhor benhor 5 minutos hace
$ACON exploding on Pre-Market 

0.0578 +0.0146 33.80%
ACON
CashCowMoo CashCowMoo 7 minutos hace
MDMP still has 469 million shares available to dilute before needing to raise the A/S. A lot of restricted will be coming available in the near future.
MDMP
luckydude777 luckydude777 10 minutos hace
ACON liftoff
ACON
CashCowMoo CashCowMoo 12 minutos hace
Yeah, doesnt look like they were really doing much. Look like they had some land but not major helium production.
RHCCF
Fiberrevo9 Fiberrevo9 13 minutos hace
Considering yesterday's trading session, the different trades, the rising pps, i am convinced that good news will be released next week.
What reassures me too is that, during last week, we had three times a peak to about 0,098, down manipulated as always, to a lower end pps, but more buys an
KBLB
gdog gdog 14 minutos hace
done
NLST
tw0122 tw0122 19 minutos hace
.05 + 15% 3m traded
ACON
Seminole Red Seminole Red 21 minutos hace
Constitutional amendment to allow Trump third term introduced in the House

A Republican House member introduced a resolution to amend the U.S. Constitution to allow President Donald Trump — and any other future president — to be elected to serve a third term.
Rep. Andy Ogles of
Guido2 Guido2 23 minutos hace
Goa. I was born here.
FNMA
MagnetLover MagnetLover 25 minutos hace
No way. Or else he would be too busy Sam Altmanning himself.
FLCX
Peter J Peter J 28 minutos hace
It took .000774 to buy those 774 shares todays. Who does this?Very good Question, Badog. A VERY good question...

May I remind you that most of the times over the last years... it was exactly the other way around!

Now, who did/does this...? And why...?

ERHE
tw0122 tw0122 28 minutos hace
$7.51 still a little left for latecomers just cash it out now 
ALUR
10thMountain 10thMountain 32 minutos hace
Speaking of stair stepping…

https://stockcharts.com/c-sc/sc?s=FDCT&p=D&yr=1&mn=0&dy=0&i=t4669085127c&r=1737710215304
FDCT
RickNagra RickNagra 35 minutos hace
Which part of India are you in ?  I know the place very well.
FNMA
tw0122 tw0122 37 minutos hace
Flip back out .53 will revisit 
BTAI
Peter J Peter J 38 minutos hace
Ntephe and insiders are getting away with violating SEC filing and disclosure requirements, with refusing to hold annual shareholder meetings, and with paying themselves undisclosed amounts from undisclosed sources of revenue.

All very true, sounds like a stock I would like to follow
ERHE
RickNagra RickNagra 41 minutos hace
Oh wow.
DBMM
tw0122 tw0122 45 minutos hace
BTAI .49 on the move in some 
BTAI
Peter J Peter J 46 minutos hace
Couldn't use these shares as collateral to buy a rotisserie chicken at Costco.
Well... that firmly explains his obsession with ERHE... 🤣

The altruist gang has combined between 10 and 20 K ERHC posts...

Strategy, remember... all for the good cause! Don't
ERHE
joeycav11 joeycav11 53 minutos hace
Were so undervalued…
With this revenue a medium biotech company can buy us and multiply there balance sheet by 6 times easy.
Obviously company is not selling cheap
Shake up is coming in pharma dont miss it
Cell therapy is the panacea and proven cures like we possess is t
AMRN
Here Today Here Today 53 minutos hace
Another train of thought is that possibly those patients in the Cohorts 1 & 2 might have been talking to their family and friends about this new drug they are on and the results they are seeing so far causing those family and friends to start researching and looking into the company and drug and the
RNAZ

Su Consulta Reciente

Delayed Upgrade Clock